BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 34593302)

  • 21. 18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Levy JP; Bezgin G; Savard M; Pascoal TA; Finger E; Laforce R; Sonnen JA; Soucy JP; Gauthier S; Rosa-Neto P; Ducharme S
    Brain; 2022 Jun; 145(5):1763-1772. PubMed ID: 34664612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional MAPT haplotypes: bridging the gap between genotype and neuropathology.
    Caffrey TM; Wade-Martins R
    Neurobiol Dis; 2007 Jul; 27(1):1-10. PubMed ID: 17555970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies.
    Karch CM; Jeng AT; Goate AM
    J Biol Chem; 2012 Dec; 287(51):42751-62. PubMed ID: 23105105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
    Coppola G; Chinnathambi S; Lee JJ; Dombroski BA; Baker MC; Soto-Ortolaza AI; Lee SE; Klein E; Huang AY; Sears R; Lane JR; Karydas AM; Kenet RO; Biernat J; Wang LS; Cotman CW; Decarli CS; Levey AI; Ringman JM; Mendez MF; Chui HC; Le Ber I; Brice A; Lupton MK; Preza E; Lovestone S; Powell J; Graff-Radford N; Petersen RC; Boeve BF; Lippa CF; Bigio EH; Mackenzie I; Finger E; Kertesz A; Caselli RJ; Gearing M; Juncos JL; Ghetti B; Spina S; Bordelon YM; Tourtellotte WW; Frosch MP; Vonsattel JP; Zarow C; Beach TG; Albin RL; Lieberman AP; Lee VM; Trojanowski JQ; Van Deerlin VM; Bird TD; Galasko DR; Masliah E; White CL; Troncoso JC; Hannequin D; Boxer AL; Geschwind MD; Kumar S; Mandelkow EM; Wszolek ZK; Uitti RJ; Dickson DW; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; ; Ross OA; Rademakers R; Schellenberg GD; Miller BL; Mandelkow E; Geschwind DH
    Hum Mol Genet; 2012 Aug; 21(15):3500-12. PubMed ID: 22556362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenic MAPT mutations Q336H and Q336R have isoform-dependent differences in aggregation propensity and microtubule dysfunction.
    Xia Y; Nasif L; Giasson BI
    J Neurochem; 2021 Jul; 158(2):455-466. PubMed ID: 33772783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge].
    Hauw JJ; Hausser-Hauw C; Duyckaerts C
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S59-70. PubMed ID: 14646802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
    Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
    Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features.
    Rossi G; Bastone A; Piccoli E; Morbin M; Mazzoleni G; Fugnanesi V; Beeg M; Del Favero E; Cantù L; Motta S; Salsano E; Pareyson D; Erbetta A; Elia AE; Del Sorbo F; Silani V; Morelli C; Salmona M; Tagliavini F
    Neurobiol Aging; 2014 Feb; 35(2):408-17. PubMed ID: 24018212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
    Kowalska A
    Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
    Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
    Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.
    Lee VM; Giasson BI; Trojanowski JQ
    Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of the tauopathies.
    Goedert M; Spillantini MG
    J Mol Neurosci; 2011 Nov; 45(3):425-31. PubMed ID: 21785996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
    Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
    J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
    Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
    Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology.
    Sato C; Mallipeddi N; Ghoshal N; Wright BA; Day GS; Davis AA; Kim AH; Zipfel GJ; Bateman RJ; Gabelle A; Barthélemy NR
    Ann Clin Transl Neurol; 2021 Sep; 8(9):1817-1830. PubMed ID: 34342183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-Alzheimer's disease dementias: anatomic, clinical, and molecular correlates.
    Hou CE; Carlin D; Miller BL
    Can J Psychiatry; 2004 Mar; 49(3):164-71. PubMed ID: 15101498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tauopathies as clinicopathological entities.
    Irwin DJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
    Wang Y; Wang J; Gao L; Stamm S; Andreadis A
    Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of 17q21.31 duplication iPSC-derived neurons as a model for primary tauopathies.
    Miguel L; Rovelet-Lecrux A; Chambon P; Joly-Helas G; Rousseau S; Wallon D; Epelbaum S; Frébourg T; Campion D; Nicolas G; Lecourtois M
    Stem Cell Res; 2022 May; 61():102762. PubMed ID: 35358831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.